Abstract |
The protective efficacy of a p55 tumor necrosis factor receptor immunoadhesin ( TNFR-IgG) was compared with that of an anti-TNF monoclonal antibody (MAb) in a rat endotoxic shock model. TNFR-IgG (5 mg/kg), given 30 min before endotoxin (LPS), attenuated LPS induction of hypotension and tachycardia and eliminated LPS induction of serum TNF activity. In contrast, anti-TNF MAb (5 mg/kg) had little effect on LPS-induced hemodynamic changes and neutralized only partially the excessive serum TNF activity. The 6-day survival was 1 of 10 controls; 6 of 11, 5 of 7, and 8 of 9 rats receiving 0.2, 1.0, or 5.0 mg/kg TNFR-IgG, respectively; and 3 of 8 rats receiving 5 mg/kg anti-TNF MAb. These results indicate that TNFR-IgG is more potent than anti-TNF MAb at neutralizing excessive TNF activity in vivo.
|
Authors | H Jin, R Yang, S A Marsters, S A Bunting, F M Wurm, S M Chamow, A Ashkenazi |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 170
Issue 5
Pg. 1323-6
(Nov 1994)
ISSN: 0022-1899 [Print] United States |
PMID | 7963738
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Immunoglobulin G
- Lipopolysaccharides
- Receptors, Tumor Necrosis Factor
- Tumor Necrosis Factor-alpha
|
Topics |
- Animals
- Antibodies, Monoclonal
(therapeutic use)
- Blood Pressure
(drug effects)
- Heart Rate
(drug effects)
- Immunoglobulin G
(therapeutic use)
- Lipopolysaccharides
(toxicity)
- Male
- Rats
- Rats, Sprague-Dawley
- Receptors, Tumor Necrosis Factor
(physiology)
- Shock, Septic
(prevention & control)
- Tumor Necrosis Factor-alpha
(physiology)
|